Abstract
A complete mesorectal resection (total mesorectal excision, TME) is essential for the curative resection of locally advanced rectal cancer. Corollaries to TME include obtaining oncologically acceptable distal and circumferential tumor-free margins. Strict adherence to these intra-operative surgical tenets within the context of multidisciplinary care help ensure optimal outcomes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Readings
Agarwal A, et al. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer. 2013;119(24):4231–41.
Fleshman J, et al. Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg. 2019;269(4):589–95.
Holliday EB, et al. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol. 2017;8(6):990–7.
Hyngstrom JR, et al. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014;109(7):652–8.
Ikoma N, et al. Impact of recurrence and salvage surgery on survival after multidisciplinary treatment of rectal cancer. J Clin Oncol. 2017;35(23):2631–8.
Malakorn S, et al. Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation? Dis Colon Rectum. 2019;62(10):1158–66.
Rickles AS, et al. High rate of positive circumferential resection margins following rectal cancer surgery: a call to action. Ann Surg. 2015;262(6):891–8.
Massarweh NN, et al. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014;32(27):2967–74.
Patel SH, et al. Circumferential resection margin as a hospital quality assessment tool for rectal cancer surgery. J Am Coll Surg. 2020;230(6):1008–18.e1005.
Paquette IM, et al. Impact of proximal vascular ligation on survival of patients with colon cancer. Ann Surg Oncol. 2018;25(1):38–45.
Rodriguez-Bigas MA, et al. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am. 2010;19(4):847–59.
Sammour T, et al. Oncological outcomes after robotic proctectomy for rectal cancer: analysis of a prospective database. Ann Surg. 2018;267(3):521–6.
Silberfein EJ, et al. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010;17(11):2863–9.
van der Valk MJM, et al. Erratum to “Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer—results of the international randomized RAPIDO-trial” [Radiother Oncol. 2020; 147:75–83]. Radiother Oncol. 2020;147:e1.
Keane C, et al. International consensus definition of low anterior resection syndrome. Dis Colon Rectum. 2020;63(3):274–84.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Messick, C.A. (2021). Mesenteric Resection in Rectal Cancer. In: Ehrenpreis, E.D., Alverdy, J.C., Wexner, S.D. (eds) The Mesenteric Organ in Health and Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-71963-0_38
Download citation
DOI: https://doi.org/10.1007/978-3-030-71963-0_38
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71962-3
Online ISBN: 978-3-030-71963-0
eBook Packages: MedicineMedicine (R0)